Menu Search
Equities

Toleranzia AB

0EH:FRA

Toleranzia AB

Actions
  • Price (EUR)0.024
  • Today's Change0.001 / 4.35%
  • Shares traded-1.00
  • 1 Year change-64.60%
  • Beta--
Data delayed at least 15 minutes, as of Apr 24 2024 07:12 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Toleranzia AB is a Sweden-based company engaged in the development of a platform technology for treatment of autoimmune diseases. The Company's main project is aimed against an autoimmune nerve-muscle disease and myasthenia gravis. The Company’s platform technology enables the development of therapies targeting the cause of the disease, which in the current situation is the usual treatment.

  • Revenue in SEK (TTM)0.00
  • Net income in SEK-7.46m
  • Incorporated2011
  • Employees--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.